Symptoms after accelerated immunisation.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 1628051.
- Also identified by PMC identifier 1882405.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To document the incidence of symptoms after accelerated immunisation with diphtheria-tetanus-pertussis vaccine. Controlled study of children immunised with adsorbed diphtheria-tetanus-pertussis vaccine at accelerated and standard schedules. Colchester and north Hertfordshire. 107 children scheduled to receive immunisation at 2, 3, and 4 months of age and 115 children scheduled to receive immunisation at 3, 4 1/2 to 5, and 8 1/2 to 11 months of age. Parentally recorded symptoms, axillary temperatures, and size of local redness and swelling at the injection site during the seven days after immunisation. In general symptoms occurred less frequently with the accelerated schedule. Proportions of parents reporting axillary temperatures greater than 37.2 degrees C or local redness or swelling greater than 2.5 cm after the third dose of vaccine were significantly reduced in the accelerated schedule group. Immunisation at 2, 3, and 4 months of age is likely to cause fewer reactions than immunisation at 3, 4 1/2 to 5, and 8 1/2 to 11 months of age.
Medical subject headings
- Diphtheria-Tetanus-Pertussis Vaccine
- Immunization
- Immunization Schedule